Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CG9E
|
|||
| Former ID |
DIB001688
|
|||
| Drug Name |
SL-11093
|
|||
| Synonyms |
CGC-11093; Trans-1,2-Bis[4-(ethylamino)butylaminomethyl]cyclopropane tetrahydrochloride
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Preclinical | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H38N4
|
|||
| Canonical SMILES |
CCNCCCCNCC1CC1CNCCCCNCC
|
|||
| InChI |
1S/C17H38N4/c1-3-18-9-5-7-11-20-14-16-13-17(16)15-21-12-8-6-10-19-4-2/h16-21H,3-15H2,1-2H3/t16-,17-/m1/s1
|
|||
| InChIKey |
BAOFSMLABBUBJP-IAGOWNOFSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025136) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.